Miltenyi Biotec
PrivateLast Round
Debt
7/4/2023
Total Funding Raised
$789.8M
Momentum Score
25 /100
Company Overview
Miltenyi Biotec is a biotechnology company that provides products and services for biomedical research, cellular therapy, and cell and gene therapy applications.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Miltenyi Biotec Comps
Public and private peers based on sector, stage, and business model.
Miltenyi Biotec Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | 7/4/2023 | ||||
| Debt | 4/23/2021 | ||||
| Debt | 4/18/2017 |
Miltenyi Biotec Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deutsche Bank Private Credit & Infrastructure | Debt |
| Bundesministerium für Bildung und Forschung | Grant |
| European Union | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 17, 2026
Grew 56% QoQ, from 9 to 14 employees.
- Jul 11, 2023
Grew 18% QoQ, from 44 to 52 employees.
Miltenyi Biotec Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Miltenyi Biotec's valuation, stock price, and market status.
Firmographic Details
HeadquartersBergisch Gladbach
Employee Range14
Year Founded1989
Last Funding7/4/2023
